IL-27 counteracts neuropathic pain development through induction of IL-10 (2020)
- Authors:
- USP affiliated authors: ALVES FILHO, JOSÉ CARLOS FARIAS - FMRP ; CUNHA, FERNANDO DE QUEIROZ - FMRP ; CUNHA, THIAGO MATTAR - FMRP ; GUIMARÃES, RAFAELA MANO - FMRP
- Unidade: FMRP
- DOI: 10.3389/fimmu.2019.03059
- Subjects: BIOMARCADORES; CITOCINAS; PREDISPOSIÇÃO GENÉTICA PARA DOENÇA; GÂNGLIOS; INTERLEUCINA 10; MEDULA ESPINHAL
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Frontiers in Immunology
- ISSN: 1664-3224
- Volume/Número/Paginação/Ano: v. 10, art. 3059, 2020
- Este artigo possui versão em acesso aberto
- URL de acesso aberto
- PDF de acesso aberto
- Versão do Documento: Versão publicada (Published version)
-
Status: Artigo publicado em periódico de acesso aberto (Gold Open Access) -
ABNT
FONSECA, Miriam das Dores Mendes et al. IL-27 counteracts neuropathic pain development through induction of IL-10. Frontiers in Immunology, v. 10, 2020Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2019.03059. Acesso em: 14 mar. 2026. -
APA
Fonseca, M. das D. M., Davoli-Ferreira, M., Santa-Cecília, F., Guimarães, R. M., Oliveira, F. F. B., Kusuda, R., et al. (2020). IL-27 counteracts neuropathic pain development through induction of IL-10. Frontiers in Immunology, 10. doi:10.3389/fimmu.2019.03059 -
NLM
Fonseca M das DM, Davoli-Ferreira M, Santa-Cecília F, Guimarães RM, Oliveira FFB, Kusuda R, Ferreira DW, Alves Filho JCF, Cunha F de Q, Cunha TM. IL-27 counteracts neuropathic pain development through induction of IL-10 [Internet]. Frontiers in Immunology. 2020 ; 10[citado 2026 mar. 14 ] Available from: https://doi.org/10.3389/fimmu.2019.03059 -
Vancouver
Fonseca M das DM, Davoli-Ferreira M, Santa-Cecília F, Guimarães RM, Oliveira FFB, Kusuda R, Ferreira DW, Alves Filho JCF, Cunha F de Q, Cunha TM. IL-27 counteracts neuropathic pain development through induction of IL-10 [Internet]. Frontiers in Immunology. 2020 ; 10[citado 2026 mar. 14 ] Available from: https://doi.org/10.3389/fimmu.2019.03059 - Pyrrolidine dithiocarbamate inhibits superoxide anion-induced pain and inflammation in the paw skin and spinal cord by targeting NF-kB and oxidative stress
- Toll like receptor 9 deficiency in neutrophil improves sepsis outcome preventing down-regulation of CXCR2
- Splenectomy increases neutrophil migration but does not affect mortality in lethal sepsis
- Targeting IL-33/ST2 signaling: regulation of immune function and analgesia
- Probucol attenuates overt pain-like behavior and carrageenan-induced inflammatory hyperalgesia and leukocyte recruitment by inhibiting NF-кB activation and cytokine production without antioxidant effects
- Targeting nitric oxide as a key modulator of sepsis, arthritis and pain
- Curcumin inhibits superoxide anion-induced pain-like behavior and leukocyte recruitment by increasing Nrf2 expression and reducing NF-kB activation
- The citrus flavanone naringenin reduces gout-induced joint pain and inflammation in mice by inhibiting the activation of NFκB and macrophage release of IL-1β
- Pericytes modulate myelination in the central nervous system
- Bosentan, a mixed endothelin receptor antagonist, inhibits superoxide anion-induced pain and inflammation in mice
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003036103.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
